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Abstract
Cognitive dysfunction is central to the schizophrenia phenotype. Genetic and functional studies have implicated Disrupted-
in-Schizophrenia 1 (DISC1), a leading candidate gene for schizophrenia and related psychiatric conditions, in cognitive
function. Altered expression of DISC1 and DISC1-interactors has been identified in schizophrenia. Dysregulated expression
of DISC1-interactome genes might, therefore, contribute to schizophrenia susceptibility via disruption of molecular systems
required for normal cognitive function. Here, the blood RNA expression levels of DISC1 and DISC1-interacting proteins were
measured in 63 control subjects. Cognitive function was assessed using neuropsychiatric tests and functional magnetic
resonance imaging was used to assess the activity of prefrontal cortical regions during the N-back working memory task,
which is abnormal in schizophrenia. Pairwise correlations between gene expression levels and the relationship between
gene expression levels and cognitive function and N-back-elicited brain activity were assessed. Finally, the expression levels
of DISC1, AKAP9, FEZ1, NDEL1 and PCM1 were compared between 63 controls and 69 schizophrenic subjects. We found that
DISC1-interactome genes showed correlated expression in the blood of healthy individuals. The expression levels of several
interactome members were correlated with cognitive performance and N-back-elicited activity in the prefrontal cortex. In
addition, DISC1 and NDEL1 showed decreased expression in schizophrenic subjects compared to healthy controls. Our
findings highlight the importance of the coordinated expression of DISC1-interactome genes for normal cognitive function
and suggest that dysregulated DISC1 and NDEL1 expression might, in part, contribute to susceptibility for schizophrenia via
disruption of prefrontal cortex-dependent cognitive functions.
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Introduction
Abnormal cognitive function is recognized as a core component
of the schizophrenia phenotype [1,2]. Cognitive deficits are often
apparent before the onset of positive symptoms, are heritable [3],
and are seen in unaffected relatives of patients [4]. Moreover,
while deficits in working memory are a good predictor of
functional outcome [5], cognitive deficits are often refractory to
current drug treatments [6].
A network of brain regions, including the prefrontal cortex
(PFC), contributes to cognition [7]. Several of these regions
demonstrate abnormal activity in schizophrenia [8]. Schizophren-
ic patients are impaired in the performance of PFC-dependent
tasks such as the N-back task, a test of working memory [9]. This
task elicits a heritable pattern of activity in the PFC [3], meaning it
can be used to assess whether ‘‘schizophrenia-risk’’ polymorphisms
exert their pathogenic effect by altering PFC function.
Variation in Disrupted in Schizophrenia 1 (DISC1) is a risk-factor for
schizophrenia [10,11] and is implicated in cognitive function in
both healthy individuals and schizophrenic patients [12].
The DISC1 protein interacts with several proteins to link
multiple cellular functions and molecular pathways, including
neuronal migration (LIS1, NDE1, NDEL1, Dixdc1), axonal
bundling and elongation (FEZ1), neural progenitor proliferation
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(GSK3b), cell cycle regulation (PCM1), neuronal signalling
(Girdin, GSK3b, PDE4), and signal transduction (Kal7, TNIK,
AKAP9) [10,13]. Polymorphisms in several genes encoding
DISC1-interactors have been associated with schizophrenia
[10,14], and altered hippocampal expression of NDEL1, FEZ1,
and LIS1 has been detected in post-mortem brains of schizo-
phrenic patients [15]. Thus, alterations in brain function that
confer risk for psychiatric illness might arise from dysfunction at
several loci in the DISC1-interactome. In support of this assertion,
Hennah and Porteous [16] have shown genetic variation in DISC1
and DISC1-interacting proteins to modulate RNA expression of
genes involved in schizophrenia-relevant processes, including
cytoskeletal functions, synaptogenesis, neurodevelopment and
sensory perception. This finding is particularly pertinent in light
of the evidence for the involvement of perturbed gene expression
in schizophrenia [17].
In this study, we test the hypotheses that: (i) genes encoding
DISC1-interactome members show coordinated expression; (ii)
expression levels of these genes are associated with cognitive
function; (iii) frontal cortical activity elicited by the N-back task is
related to the expression of genes whose expression level is
associated with cognitive function; and (iv) the expression of genes
whose expression correlates with cognitive function is abnormal in
schizophrenic patients. We demonstrate associations between: (i)
the expression levels of several DISC1-interactome members; (ii)
DISC1-interactome members’ expression levels and cognitive
performance; and (iii) genes whose expression is related to
cognitive performance and frontal cortical activity. Moreover,
we find the expression of DISC1 and NDEL, whose expression
levels correlate with cognitive performance, to be reduced in the
blood of schizophrenic patients.
Materials and Methods
Ethics Statement
Procedures were carried out in accordance with The Code of
Ethics of the World Medical Association (Declaration of Helsinki)
and approval was given by the local ethics committee (‘‘Comitato
Etico Indipendente Locale-Azienda Ospedaliera Ospedale Policli-
nico Consorziale di Bari’’), who examined the study protocol and
the suitability of the environment and investigators involved.
Participants gave written informed consent. The capacity of
participants to consent was assessed by a psychiatrist. If
participants were not deemed capable of giving informed consent,
a legal representative gave consent on their behalf. In accordance
with Articles 414 and 415 of the Civil Code, the Legal
Representative was a member of the patient’s family, a clinician
or a lawyer nominated by the Local Court in order to represent
the patient’s civil rights.
Subjects
We examined 63 control subjects (age: mean= 26.2, standard
deviation (SD) = 5.4; 36 females) and 69 subjects with schizophre-
nia (age: mean= 37.3, SD=10.8, 16 females). Control subjects
were screened using the Non-Patient Structured Clinical Interview
for DSM-IV to ensure they were unaffected by any psychiatric
condition. In addition, control subjects were screened using the
Family Interview for Genetic Studies [18] to ensure absence of
psychotic disorders in their first-degree relatives. Diagnosis of
schizophrenia was made using the Structured Clinical Interview
for the DSM-IV Axis 1 disorders, which was administered by
psychiatrists. Both patients and control subjects were excluded if
they had: a significant history of drug or alcohol abuse; active drug
abuse in the previous year; experienced a head trauma with a loss
of consciousness; or if they suffered from any other significant
medical condition.
Gene Expression Levels
Blood for RNA extraction was collected using the Tempus
Blood Collection System (Applied Biosystems). RNA was extracted
from 3 ml whole blood using Tempus Blood RNA Isolation Kits
and subsequently reverse transcribed using Transcriptor First
Strand cDNA Synthesis Kits (Roche Applied Science). mRNA
expression was measured by quantitative reverse-transcription
polymerase chain reaction (qRT-PCR), using TaqMan probe-
based assays (Applied Biosystems; see Table S1 in File S1 for probe
IDs). Reactions were performed using an ABI Prism 7900
Sequence Detection System (Applied Biosystems), at the Wellcome
Trust Clinical Research Facility, Edinburgh. Assays spanned an
exon-exon boundary and amplified the maximum possible
number of isoforms. Expression levels were calculated using the
relative standard curve method and gene-of-interest expression
levels (DISC1, AKAP9, FEZ1, GSK3b, LIS1, NDE1, NDEL1, PCM1,
PDE4B, PDE4D) were normalised to the geometric mean of two
reference genes (RPLPO and HNRNPD). These reference genes
were selected on the basis of geNorm analysis [19], which showed
these genes to be stably expressed in a representative sub-set of the
blood samples assessed in this study (N= 15 schizophrenic patients
and 15 controls). Each sample was measured in technical
triplicate. Between-plate differences were accounted for by
normalisation to a calibrator. Outliers were identified and
excluded following Burns et al. [20].
Cognitive Assessment
All subjects were assessed with a battery of cognitive tests
comprising the: (i) N-Back paradigm (2-back condition); (ii)
Continuous Performance Test, assessing sustained attention; (iii)
Wechsler Memory scale, giving a memory quotient; (iv) Wisconsin
Card Sorting Test, evaluating executive functions; (v) Trail
Making A and B, assessing cognitive flexibility; and (vi) Controlled
Oral Word Association Test (Benton, 1967), measuring Semantic
Fluency and Phonological Fluency. For further details, see File S1
Materials and Methods.
Gene-by-gene Expression Interactions
Pearson pairwise correlation coefficients were calculated for
each pair of gene expression levels using SPSSv17.0 software
(www.spss.com). To control for the effects of multiple testing,
permutation analysis (105 permutations) was performed using
Resampling (http://core.ecu.edu/psyc/wuenschk/StatHelp/
Resampling.htm, East Carolina University) which adopts a
classical ‘‘randomization without replacement’’ algorithm. The
same software was used to derive 95% bootstrap confidence
intervals for correlation coefficients. Bootstrapping was conducted
by running a total of 105 re-samples drawn pairwise from our
original sample. Corrected p#0.05 indicated statistical signifi-
cance.
Association between Gene Expression and Cognitive
Performance
Principal component analysis. Principal component anal-
ysis (PCA) on a correlation matrix followed by varimax rotation,
retaining factors with an eigenvalue $1 was used to group
cognitive functions. In addition to providing an insight into the
architecture of cognitive function, this approach reduces the
number of dependent variables, thus reducing the type 1 error rate
[21,22].
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Correlation of gene expression with cognition. Multiple
regression analysis with backward stepwise removal was conducted
for the expression levels of ten genes against the scores obtained for
each of the four principal components (PCs). The variable with the
smallest partial correlation with the dependent variable was
considered for removal first, and removed if the significance level
of its F-value was p.0.05. For all PCs, a higher score indicated
better performance. For each analysis, the model with the highest
R2 and the lowest p-value was taken to best explain the variance
within the relevant PC. All gene expression levels and their
pairwise interactions were then regressed within each model
against the relevant PC. The threshold for statistical significance
was p#0.05. Analyses were conducted using SPSSv.17.0.
fMRI Paradigm
The fMRI experimental paradigm consisted of the N-back task,
as described previously [23]. The stimuli consisted of numbers (1–
4) shown in random sequence and displayed at the points of a
diamond-shaped box. A non-memory-guided control condition (0-
back) presented the same stimuli but simply required subjects to
identify the current stimulus. In the working memory condition,
the task required recollection of a stimulus seen two stimuli
previously (2-back). Performance data were recorded as the
percentage of correct responses and reaction time (msecs).
Echo planar imaging blood oxygenation level dependent fMRI
data were acquired as described previously [23] (TE= 30 m secs,
TR=2 secs, 20 contiguous slices, voxel size = 3.7563.7565) on a
GE 3T scanner with a standard head coil. A simple block design
was used in which each block consisted of 8 alternating 0-back and
2-back conditions (each 30 secs), obtained in 4 min and 8 secs,
120 whole-brain fMRI volumes. The first four scans of the time
series were discarded to allow for signal equilibration effects.
fMRI Data Analysis
Images were pre-processed using Statistical Parametric Map-
ping 8 software (SPM8; http://www.fil.ion.ucl.ac.uk/spm). Images
were realigned to the first volume in the time series to correct for
head motion (,2 voxels translation,,1u rotation), re-sampled to a
2 mm isotropic voxel size, spatially normalized into a standard
stereotactic space (Montreal Neurological Institute template) using
a 12 parameter affine model and smoothed to minimize noise and
residual differences in gyral anatomy with a Gaussian filter, set at
6 mm full-width at half-maximum. Voxel-wise signal intensities
were ratio normalized to the whole-brain global mean. For each
experimental condition, a box-car model convolved with the
haemodynamic response function at each voxel was modelled.
Pre-determined condition effects at each voxel were calculated
using a t-statistic, producing a statistical image for the contrast of
2-back versus 0-back. Individual contrast images were then used in
second-level random effects models to determine task-specific
regional responses at the group level for the entire sample.
To assess the association between gene expression and fMRI
activation, contrast images of all subjects were used as dependent
variables in a general linear model using SPM8. A priori evidence
for involvement of the frontal cortex in the N-back task [3,9]
meant this region was of particular interest. Regions of interest
(ROIs) were specified by dividing the frontal cortex into its
constituent Brodmann Areas (BAs), as defined by the WFU_Pick-
Atlas [24]. Within each ROI, a family wise error (FWE) small
volume correction with a p#0.05 was applied to control for type I
errors.
Comparison of Gene Expression Levels in Patients with
Schizophrenia and Healthy Controls
Case-control comparisons were carried out for AKAP9, DISC1,
FEZ1, NDEL1 and PCM1 expression levels. To assess the influence
of potentially confounding variables, the effects of age and gender
on expression were assessed for each gene using one-way analysis
of variance (ANOVA) and linear regression analysis, respectively.
Comparisons of gene expression levels between schizophrenic
patients and controls were made using either ANOVA or analysis
of covariance (ANCOVA) with the independent variable of
diagnostic status and the dependent variable of expression level.
Covariates were included where appropriate.
Results
Gene-by-gene Expression Interactions
In the control subjects, we assessed correlations between RNA
expression levels of DISC1 and nine DISC1-interactors by
calculating Pearson correlation coefficients for each pair-wise
combination. Following correction for multiple testing by permu-
tation and bootstrap analyses, DISC1 expression showed significant
correlation with AKAP9, GSK3b, and NDEL1. Several other
significant pair-wise correlations were detected (Table 1; Figure
S1 in File S1).
Principal Component Analysis of Cognitive Test Data
As we had carried out multiple related cognitive tests we defined
a set of linearly independent cognitive variables using principal
component analysis (PCA). PCA revealed four principal compo-
nents (PCs) that together explained 66.5% of the variance in
cognitive performance (p=0.003; Figure 1; Table S2 in File S1).
Correlation between Gene Expression and Cognitive
Performance
To explore the correlation between gene expression and
cognition we carried out backward removal multiple regression
analysis of gene expression levels against the four PCs. For each
PC, variation in the expression of either a single gene or a
combination of genes was found to explain a significant proportion
of the variance (Table 2). We next examined the effect of gene-by-
gene interactions within PCs 2, 3 and 4 (PC1 was best explained
by a single-gene model). Backward removal multiple regression
analysis revealed that inclusion of interaction terms improved the
fit and significance of each model (Table 3; Figure S2 in File S1).
The combination of genes and gene6gene interactions that best
explained variation in each PC will henceforth be referred to as
the ‘‘expression model’’.
Correlation between Gene Expression and Frontal
Cortical Function
We assessed the relationship between the four expression
models and N-back-elicited frontal cortical activity, as measured
by fMRI, in the control subjects. Several findings at the fMRI level
were consistent with findings at the behavioural level (Table 4;
Table S3 in File S1).The PC 2, 3, and 4 expression models showed
significant relationships with the activity of frontal regions (Figures
S3 and S4 in File S1). The PC1 expression model showed a
nominally significant relationship with activity in BA 9 (uncor-
rected p,0.0001); however, this relationship did not withstand
multiple testing correction (corrected p=0.093).
The DISC1-Interactome and Cognition
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Comparison of the Expression Levels of DISC1-
Interactome Members in Schizophrenic Patients and
Healthy Controls
The expression levels of five members of the DISC1-inter-
actome whose expression was correlated with cognitive perfor-
mance in control subjects (AKAP9, DISC1, FEZ1, NDEL1, and
PCM1) were measured in the peripheral blood of schizophrenic
patients. As age significantly affected DISC1 expression (p=0.012),
it was included as a covariate in the DISC1 analysis. Comparing
schizophrenic patients to controls revealed significant differences
in DISC1 (p=0.0015, ANCOVA) and NDEL1 (p=0.028,
ANOVA) expression. Both genes showed reduced RNA expres-
sion in schizophrenic patients (DISC1: mean=1.33, SD=0.810;
NDEL1: mean= 1.88, SD=0.294) relative to controls (DISC1:
mean= 2.10, SD=1.20; NDEL1: mean= 2.15, SD=0.936).
Discussion
Multiple lines of evidence support a role for variation in DISC1
and DISC1-interactors in conferring risk for psychiatric illness
[10,11], potentially, in part, via an effect on cognitive function
[12]. DISC1’s role as a molecular scaffold [10] suggests that the
coordinated expression of DISC1-interactome members is essen-
tial for normal brain development and function, and that
alteration may result in cognitive deficits and susceptibility to
psychiatric illness.
Here, in healthy individuals, we demonstrated significant
correlations between the expression levels of several members of
the DISC1-interactome. Moreover, RNA expression of five of
these genes (AKAP9, DISC1, FEZ1, NDEL1, and PCM1) correlated
with cognitive performance. Cognitive function, as assessed by
several measures, was reduced to four PCs. The expression level of
at least one DISC1-interactome gene was significantly correlated
with each PC. Interestingly, where multiple genes best explained
performance, the majority of these genes showed significant
between-gene correlations in their expression levels. It is notewor-
thy that genes showing correlated expression often conferred
opposite effects on cognitive function. Furthermore, the inclusion
of interaction terms improved the fit and the significance of the
models. These findings are suggestive of a complex scenario
whereby members of gene pairs showing correlated expression
contribute to cognitive function via both independent and
overlapping mechanisms. Our findings suggest that it is unlikely
that genes showing correlated expression contribute to the same
cognitive PC via a mechanism that simply involves one gene
regulating the expression of the other and, thus, conferring an
effect on cognition. Nevertheless, it would be of interest in the
future to perform experiments in vitro to establish whether
manipulating the expression level of one member of a correlated
gene pair alters the expression of the other member of the gene
pair. Our results indicate the inter-dependency of DISC1-
interactome members and highlight the possibility for variation
in their expression levels to confer risk for schizophrenia via a
deleterious effect on cognition.
We report that N-back task-elicited activity in BAs 9, 45, and 6
is correlated with the PC1, PC2, PC3, and PC4 expression models.
Our observation of N-back task-elicited activity in these regions is
consistent with previous studies [25]. The expression models for
PCs 1, 2, and 4 correlated with activity in BAs 9 and 45, regions
that have been implicated in working memory function [25,26].
BA6 has traditionally been viewed as motor cortex; however, the
observation that this area is active in non-motor mental operation
tasks that require the updating of spatial and verbal representa-
tions in memory suggests it may subserve both cognitive and
motor functions [27,28]. PC3, the cognitive model for which
expression correlated with BA6 activity, related to phonological
Table 1. Gene co-expression within the DISC1-interactome.
Co-expressed
gene pair
Pearson
correlation
coefficient (r)
Uncorrected
p-value
(2-tailed)
Corrected
p-valuea
95% bootstrap
Confidence
interval
DISC16AKAP9 +0.27 0.046 0.048 0.012; 0.53
DISC16GSK3b 20.35 0.0082 0.012 20.55; 20.34
DISC16NDEL1 +0.29 0.036 0.036 0.038; 0.51
AKAP96 FEZ1 +0.42 0.0033 0.0052 0.14; 0.42
AKAP96 PCM1 +0.39 0.0032 0.0052 0.036; 0.39
FEZ16NDE1 20.45 0.0012 0.0012 20.68; 20.18
NDE16GSK3b +0.57 0.000033 0.000055 0.37; 0.72
NDE16NDEL1 +0.32 0.033 0.033 0.003; 0.56
GSK3b6 PDE4B +0.32 0.023 0.041 0.11; 0.32
aCorrected by permutation analysis (105 permutations).
doi:10.1371/journal.pone.0099892.t001
Figure 1. Graphical depiction of the principal components
derived from performance on the neurocognitive tests. Four
principal components were defined by principal components analysis.
Each principal component was named according to the specific
cognitive functions assessed by the tests that loaded onto it.
doi:10.1371/journal.pone.0099892.g001
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fluency and speed of processing. Interestingly, activity in BA6 has
previously been found to correlate with response rate on a word
fluency task [29].
Within each expression model, the effect of each gene on N-
back task-elicited activity depended on the expression of the other
DISC1-interactome genes in the model and the specific brain
region considered. Furthermore, significant correlations were
observed between several gene-by-gene interaction terms and
frontal cortical activity. For genes contributing to PCs 2, 3 and 4,
the relationship between gene expression and N-back task-elicited
activity was in the opposite direction for the gene-by-gene
interaction terms and the related main effects. This pattern of
results is compatible with a scenario whereby genes contributing to
a given PC act via both mutually dependent and independent
pathways, which confer opposite effects on the activity of a given
brain region in response to changes in gene expression. These
findings support a functional interaction between DISC1-inter-
actome members, adding to our understanding of their known
cellular interactions, and highlight the need to consider genetic
variables in the context of their appropriate biological networks.
Moreover, we are the first to report a correlation between the
expression of a gene in the blood and frontal cortical activity.
Of the five genes whose expression correlated with cognitive
function in healthy controls, DISC1 and NDEL1, showed reduced
expression in schizophrenic patients. This finding is in keeping
with the positive correlation between DISC1 and NDEL1
expression observed in control subjects. In light of this result,
one possibility is that the reduced expression of both genes in
schizophrenic patients reflects the inter-dependency of the
expression levels of these genes. This possibility could be assessed
in vitro by manipulating the expression level of each gene
individually and measuring the expression of the other gene.
Our study is the first to compare the peripheral blood
expression of NDEL1 between patients and controls and is
consistent with a previous study, which demonstrated reduced
NDEL1 plasma activity in schizophrenia [30]. In contrast to our
findings, a recent study found DISC1 RNA expression to be
increased in peripheral blood mononuclear cells (PBMCs) from
treatment-naive patients with schizophrenia and to remain
increased following six to eight weeks of antipsychotic treatment
[31]. The discrepancy with our findings is, therefore, unlikely to be
attributable to treatment effects, with the caveat that antipsychotic
treatment may take longer than eight weeks to alter DISC1
expression. Another potential explanation for this discrepancy is
the difference in the cellular composition (whole blood vs. PMBCs)
of the RNA source. Our finding of reduced DISC1 expression is
consistent with our previous work [32], where we observed ,50%
reduction in DISC1 protein expression in lymphoblastoid cell lines
derived from carriers of at (1;11) translocation that disrupts DISC1
and is a strong genetic risk factor for psychiatric illness [33].
Table 2. Relationship between the expression levels of DISC1-interactome genes and cognitive performance.
PCa
Cognitive
functions assessed Modelb
b
coefficient
p-
value
Whole
model
p-value
Whole
model R2
1 Working Memory –Attention NDEL1 +0.34 0.02 0.023 0.12
2 Memory -Perseverative Errors AKAP9
FEZ1
PCM1
+0.48
20.47
20.38
0.002
0.002
0.01
0.0014 0.35
3 Phonological Fluency - Speed of Processing DISC1
NDEL1
+0.28
20.38
0.072
0.015
0.029 0.16
4 Semantic Fluency DISC1
AKAP9
20.26
+0.41
0.067
0.002
0.0052 0.23
aPC =principal component.
bThe model explaining the most variation within each PC was determined by backward removal multiple regression analysis including main effects only.
doi:10.1371/journal.pone.0099892.t002
Table 3. Relationship between the expression levels of DISC1-interactome genes and their pairwise interactions and cognitive
performance.
PCa Modelb
b
coefficient p-value
Whole model
p-value
Whole
model R2
2 AKAP9
FEZ1
PCM1
FEZ16 PCM1
+0.41
20.45
20.34
20.65
0.0028
0.0021
0.015
0.000019
0.00038 0.38
3 NDEL1
DISC1
NDEL16DISC1
20.39
+0.33
20.65
0.004
0.014
0.0058
0.0052 0.21
4 AKAP9
DISC1
AKAP96DISC1
+0.47
20.26
20.28
0.00046
0.038
0.0003
0.0013 0.23
aPC =principal component.
bThe model explaining the most variation within each PC was determined by backward removal multiple regression analysis including main effects and gene-by-gene
interaction terms.
doi:10.1371/journal.pone.0099892.t003
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Further studies are required to characterise the relationship
between blood expression of DISC1 and schizophrenia.
Assaying expression in peripheral blood rather than post-
mortem brains avoids the confounds of agonal conditions and
post-mortem delay, which can affect RNA integrity and thus gene
expression [34,35]. Cognisant of these caveats, it should be noted
that Lipska et al. [15] found the hippocampal mRNA expression
of NDEL1 but not DISC1 to be reduced in schizophrenic patients.
In contrast, ,75 kDa DISC1 hippocampal protein expression was
found to be increased in schizophrenic patients [15]. A recent
study identified decreased 91 kDa DISC1 immunoreactivity in the
dorsolateral prefrontal cortex (DLPFC) in schizophrenic patients
[36], while studies of DISC1 mRNA expression in this region have
found no differences between schizophrenic patients and controls
[15,37]. There are several possible explanations for the apparent
discrepancies between these studies: schizophrenia-associated
changes in gene expression might be isoform, tissue- and/or brain
region- specific; and/or aetiological heterogeneity might have
resulted in systematic between-study sample differences. It is clear
that further studies are required to distinguish between these
possibilities.
While the relevance of blood expression to brain expression is a
subject of debate, the use of blood RNA is a practical necessity
when conducting within-subjects studies of gene expression and
cognition. Additional studies in which blood and brain expression
are compared within-samples would aid in the interpretation of
blood-based expression findings; however, regardless of the
relationship between blood and brain expression levels, our
findings provide encouragement for the possibility raised by
previous studies that blood-based gene expression profiling may
eventually aid in diagnosis [38,39].
In summary, this study highlights the contribution of the
coordinated expression of DISC1-interactome genes to cognitive
functions relevant to schizophrenia. Future studies should attempt
to clarify the specificity of the relationship between the expression
levels of DISC1-interactome members and sub-domains of
cognitive function in independent samples of healthy controls, as
well as attempting to replicate our findings of aberrant expression
in schizophrenic patients. In addition it would be of interest to (i)
assess the relationship between the expression of DISC1 and
NDEL1 and cognitive function in schizophrenic patients and (ii)
identify the molecular processes affected by the altered expression
of these genes. Such studies have the potential to both identify new
targets for therapeutic action, thus permitting the development of
medications with greater efficacy in ameliorating the cognitive
deficits of schizophrenia, and identify blood-based biomarkers,
thus improving diagnosis.
Supporting Information
File S1 Table S1, Details of TaqMan probes used for qRT-
PCR. List of TaqMan (Applied Biosystems) probes used to explore
expression levels in ten genes of the DISC1 interactome. Probes
were chosen to span an intron-exon boundary and to amplify the
maximum possible number of isoforms possible. Table S2, Factor
loadings of cognitive tasks. Factors with eigenvalues of at least 1
were identified by principal components analysis followed by
varimax rotation. For each cognitive test, the function explored is
detailed together with the loading of the test on each of the four
identified factors. Table S3, Assessment of the effect of gene
expression levels on prefrontal cortical activity elicited by the N-
back task. Correlations were assessed between gene expression and
activity in prefrontal cortex during the N-back task (2-back
condition). For each correlation, the Brodmann’s area (BA)
involved, Talairach coordinates, k values, z-score, and familywise
error (FWE) rate corrected p-value are indicated. Where a p-value
did not survive multiple testing correction, this is indicated and the
uncorrected p-value is presented. Figure S1, Patterns of co-
expression amongst DISC1 pathway genes. Graphical represen-
tation of the co-expression patterns amongst DISC1 and nine
DISC1-interactor genes. Lines between pairs of genes represent
significant positive (continuous lines) and negative (dashed lines)
Pearson correlations. Line width represents a visual proxy of
correlation strength, as indicated. Figure S2, Heat map represen-
tations of the relationship between the expression of DISC1
pathway genes and cognitive performance. Depicted are heat
maps representing the relationship between A. changes in PC3
(Phonological Fluency-Speed of Processing) in relation to changes
in expression levels of DISC1 and NDEL1, and B. changes in PC4
(Semantic Fluency) in relation to changes in expression levels of
DISC1 and AKAP9. Figure S3, Relationship between DISC1 and
NDEL1 expression levels and frontal cortex function. The
relationship between frontal cortical activity elicited by the N-
back task and the expression levels of NDEL1, DISC1, and the
interaction between NDEL1 and DISC1 expression was assessed
using the general linear model. A. Heat map graphical
Table 4. Relationship of gene expression levels to activity in the prefrontal cortex elicited by the N-back task.
PCa
Regression term
(gene/gene6gene
interaction)
Brodmann area
showing significantly
correlated activity
Direction of
correlation
Corrected
p-valueb
Whole model
p-value
1 NDEL1 9 POSITIVE 0.093 0.093
2 AKAP9
PCM1
FEZ1
FEZ16 PCM1
9
45
45
45
NEGATIVE
NEGATIVE
NEGATIVE
POSITIVE
0.035
0.029
0.040
0.026
0.01
3 NDEL1
DISC1
NDEL16DISC1
6
6
6
NEGATIVE
NEGATIVE
POSITIVE
0.025
0.023
0.022
0.00083
4 AKAP9
DISC1
AKAP96DISC1
9
9
9
POSITIVE
POSITIVE
NEGATIVE
0.019
0.007
0.009
0.00078
aPC =principal component.
bCorrected by permutation analysis (105 permutations).
doi:10.1371/journal.pone.0099892.t004
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representation of changes in fMRI BOLD signal in BA 6 during
the N-back task in relation to changes in expression levels of
DISC1 and NDEL1. B. Negative main effect of NDEL1
expression level on BA 6 activity during the N-back task when
including NDEL1 expression level, DISC1 expression level and
the DISC1-by-NDEL1 interaction term in the model. C. Negative
main effect of DISC1 expression level on BA 6 activity during the
N-back task when including NDEL1 expression level, DISC1
expression level and the NDEL1-by-DISC1 interaction term in the
model. D. Positive effect of the interaction term, DISC1-by-
NDEL1 expression level, on BA 6 activity during the N-back task
when including NDEL1, DISC1, and the DISC1-by-NDEL1
interaction term in the model. Figure S4, Relationship between
AKAP9 and DISC1 expression levels and prefrontal cortex
function. The relationship between frontal cortical activity elicited
by the N-back task and the expression levels of AKAP9, DISC1,
and the interaction between AKAP9 and DISC1 expression was
assessed using the general linear model. The model included
AKAP9 expression level, DISC1 expression level and the AKAP9-
by-DISC1 interaction. A. Heat map graphical representation of
changes in fMRI BOLD signal in BA 6 during the N-back task in
relation to changes in expression levels of DISC1 and AKAP9. B.
Positive main effect of DISC1 expression level on BA 9 activity
during the N-back task when including AKAP9 expression level,
DISC1 expression level and the DISC1-by-AKAP9 interaction
term in the model. C. Positive main effect of AKAP9 expression
level on BA 9 activity during the N-back task when including
AKAP9 expression level, DISC1 expression level and the DISC1-
by-AKAP9 interaction term in the model. D. Negative effect of the
AKAP9-by-DISC1 interaction on BA 9 activity during the N-back
task when including AKAP9, DISC1 and the DISC1-by-AKAP9
interaction term in the model.
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